P3 Health Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,445	1,500	1,266	1,049	637.36	491.06
Revenue Growth (YoY)	-2.15%	18.48%	20.67%	64.66%	29.79%	237.54%
Cost of Revenue	1,503	1,559	1,235	1,057	659.34	484.5
Gross Profit	-58.45	-58.92	31.64	-7.75	-21.98	6.56
Selling, General & Admin	109.04	120.13	125.6	162.38	119.41	54.89
Other Operating Expenses	1.26	53.7	-12.71	-11.46	37.84	-20.54
Operating Expenses	194.63	259.88	199.57	238.21	165.97	35.15
Operating Income	-253.08	-318.8	-167.93	-245.96	-187.95	-28.59
Interest Expense	-46.23	-22.17	-15.99	-11.4	-10.68	-2.53
Other Non Operating Income (Expenses)	9.4	23.57	0.18	12.62	-5.72	-0.29
EBT Excluding Unusual Items	-289.91	-317.4	-183.73	-244.74	-204.34	-31.41
Impairment of Goodwill	-	-	-	-1,315	-	-
Gain (Loss) on Sale of Assets	13.27	13.27	-	-	-	-
Asset Writedown	-8.06	-8.06	-	-	-	-
Other Unusual Items	6.2	6.2	-	-	-	-
Pretax Income	-278.5	-305.99	-183.73	-1,560	-204.34	-31.41
Income Tax Expense	8.02	4.39	2.7	1.86	-	-
Earnings From Continuing Operations	-286.52	-310.38	-186.43	-1,562	-204.34	-31.41
Minority Interest in Earnings	155.47	174.53	128.65	1,291	47.86	-
Net Income	-131.05	-135.85	-57.77	-270.13	-156.48	-31.41
Preferred Dividends & Other Adjustments	-	-	-	-	-146.4	-
Net Income to Common	-131.05	-135.85	-57.77	-270.13	-10.08	-31.41
Shares Outstanding (Basic)	3	3	2	1	1	1
Shares Outstanding (Diluted)	3	3	6	1	1	1
Shares Change (YoY)	22.33%	-50.10%	608.51%	-	-36.84%	38.34%
EPS (Basic)	-40.16	-46.79	-30.44	-324.84	-12.12	-23.86
EPS (Diluted)	-42.95	-54.06	-31.64	-325.00	-12.12	-23.86
Free Cash Flow	-122.87	-110.13	-77.86	-128.25	-69.88	-27.52
Free Cash Flow Per Share	-37.66	-37.46	-13.21	-154.23	-84.03	-20.90
Gross Margin	-4.04%	-3.93%	2.50%	-0.74%	-3.45%	1.34%
Operating Margin	-17.52%	-21.25%	-13.26%	-23.44%	-29.49%	-5.82%
Profit Margin	-9.07%	-9.05%	-4.56%	-25.74%	-1.58%	-6.40%
Free Cash Flow Margin	-8.50%	-7.34%	-6.15%	-12.22%	-10.96%	-5.61%
EBITDA	-168.76	-232.74	-81.26	-158.67	-179.22	-27.79
EBITDA Margin	-11.68%	-15.51%	-6.42%	-15.12%	-28.12%	-5.66%
D&A For EBITDA	84.32	86.06	86.68	87.29	8.72	0.8
EBIT	-253.08	-318.8	-167.93	-245.96	-187.95	-28.59
EBIT Margin	-17.52%	-21.25%	-13.26%	-23.44%	-29.49%	-5.82%
Revenue as Reported	1,445	1,500	1,266	1,049	637.36	491.06
Advertising Expenses	-	1.3	3.2	4.5	2.1	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q